Asymmetric Therapeutics, LLC
Records under this name other than the patents Asymmetric Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 9 of 9 · Back to Asymmetric Therapeutics, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,979,688 | Treatment method against side-effects of chemotherapy Term ended Term ended Feb 12, 2023 · USPTO record | Term ended | Term ended Feb 12, 2023 | USPTO record |
| US 6,995,165 | Methods, compositions, and kits for organ protection during systemic anticancer therapy Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 7,368,456 | Methods, compositions, and kits for organ protection during systemic anticancer therapy Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 7,662,829 | Methods, compositions, and kits for organ protection during systemic anticancer therapy Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 7,812,030 | Methods, compositions, and kits for organ protection during systemic anticancer therapy Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 7,816,366 | Compositions and methods for treating and preventing dermatoses Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 8,258,147 | Compositions and methods for treating and preventing dermatoses Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 9,084,788 | Compositions and methods for treating and preventing dermatoses Term ended Ended no later than Feb 12, 2023 · USPTO record | Term ended | Ended no later than Feb 12, 2023 | USPTO record |
| US 8,653,090 | Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents Formerly held Lapsed on the fee record Ended Feb 18, 2022 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2022 | USPTO record |